Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001689375-23-000029
Filing Date
2023-04-19
Accepted
2023-04-19 17:50:31
Documents
1
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_168194101787371.html 4/A  
1 FORM 4/A wf-form4a_168194101787371.xml 4/A 6971
  Complete submission text file 0001689375-23-000029.txt   8368
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address
Sethuraman Natarajan (Reporting) CIK: 0001873394 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40969 | Film No.: 23830927